![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: NFXL1 |
Gene summary for NFXL1 |
![]() |
Gene information | Species | Human | Gene symbol | NFXL1 | Gene ID | 152518 |
Gene name | nuclear transcription factor, X-box binding like 1 | |
Gene Alias | CDZFP | |
Cytomap | 4p12 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | B1Q2B0 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
152518 | NFXL1 | male-WTA | Human | Thyroid | PTC | 9.01e-06 | 5.77e-02 | 0.1037 |
152518 | NFXL1 | PTC05 | Human | Thyroid | PTC | 4.53e-07 | 2.36e-01 | 0.2065 |
152518 | NFXL1 | PTC06 | Human | Thyroid | PTC | 6.08e-14 | 3.69e-01 | 0.2057 |
152518 | NFXL1 | PTC07 | Human | Thyroid | PTC | 5.69e-08 | 2.10e-01 | 0.2044 |
152518 | NFXL1 | ATC12 | Human | Thyroid | ATC | 9.68e-05 | 1.32e-01 | 0.34 |
152518 | NFXL1 | ATC13 | Human | Thyroid | ATC | 9.87e-37 | 6.73e-01 | 0.34 |
152518 | NFXL1 | ATC2 | Human | Thyroid | ATC | 9.96e-03 | 2.77e-01 | 0.34 |
152518 | NFXL1 | ATC4 | Human | Thyroid | ATC | 2.89e-10 | 1.72e-01 | 0.34 |
152518 | NFXL1 | ATC5 | Human | Thyroid | ATC | 4.68e-46 | 7.18e-01 | 0.34 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Thyroid | ![]() | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis | ||
PTC: Papillary thyroid cancer |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Thyroid | PTC | ![]() |
Thyroid | goiters | ![]() |
Thyroid | ATC | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
NFXL1 | SNV | Missense_Mutation | novel | c.2636N>G | p.Val879Gly | p.V879G | Q6ZNB6 | protein_coding | tolerated(0.37) | benign(0) | TCGA-A8-A095-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | CR |
NFXL1 | SNV | Missense_Mutation | rs770685540 | c.1295G>A | p.Arg432His | p.R432H | Q6ZNB6 | protein_coding | deleterious(0) | probably_damaging(0.991) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
NFXL1 | SNV | Missense_Mutation | c.2157N>T | p.Leu719Phe | p.L719F | Q6ZNB6 | protein_coding | deleterious(0.05) | benign(0.219) | TCGA-AR-A24Z-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD | |
NFXL1 | deletion | Frame_Shift_Del | novel | c.1640delN | p.Pro547HisfsTer56 | p.P547Hfs*56 | Q6ZNB6 | protein_coding | TCGA-D8-A27V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD | ||
NFXL1 | SNV | Missense_Mutation | c.2613N>A | p.Asn871Lys | p.N871K | Q6ZNB6 | protein_coding | tolerated(1) | benign(0) | TCGA-IR-A3LB-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PD | |
NFXL1 | SNV | Missense_Mutation | novel | c.1634N>A | p.Thr545Lys | p.T545K | Q6ZNB6 | protein_coding | deleterious(0) | possibly_damaging(0.649) | TCGA-VS-A94Z-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
NFXL1 | SNV | Missense_Mutation | c.2269A>C | p.Asn757His | p.N757H | Q6ZNB6 | protein_coding | tolerated(0.12) | benign(0) | TCGA-AA-3510-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
NFXL1 | SNV | Missense_Mutation | novel | c.380N>T | p.Thr127Met | p.T127M | Q6ZNB6 | protein_coding | deleterious(0.01) | possibly_damaging(0.568) | TCGA-AA-3845-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
NFXL1 | SNV | Missense_Mutation | c.2411N>T | p.Arg804Ile | p.R804I | Q6ZNB6 | protein_coding | deleterious(0) | probably_damaging(0.986) | TCGA-AA-3977-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
NFXL1 | SNV | Missense_Mutation | rs372423597 | c.1169N>A | p.Arg390Gln | p.R390Q | Q6ZNB6 | protein_coding | deleterious(0.03) | probably_damaging(0.943) | TCGA-AA-3984-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |